Novel prognostic score for patients with metastatic bladder cancer on immunotherapy using real-world data Chauhan 1, S. Silva Diaz 2, P. Jara Martin 3, A. Gurung 4, M. Young 1, C. Wells 1, E....
Efficacy and toxicity of half dose BCG therapy in bladder cancer Acharya 1 (1) Assam Cancer Care Foundation, Lakhimpur - India Objective: Bacillus Calmette–Guérin (BCG) has been successfully...
External validation of the novel prognostic Meet-URO score in Metastatic Renal Cell Carcinoma on First Line Immune-combination therapy Authors Aruni Ghose1, Alessio Signori2, Nicholas Brown3,...
Clinical parameters for first-line immuno-combinations choice in metastatic renal cell carcinoma (mRCC) patients (pts): the Meet-URO 33 study Bimbatti 1, A. Signori 2, U. Basso 1, L. Fratino...
Baseline characteristics as parameters of choice of first-line therapy in metastatic renal cell carcinoma (mRCC) patients (pts): the Meet-URO 33 study S.E. Rebuzzi 1, A. Signori 2, G....
Clinical response of advanced renal carcinoma’s patients treated with small immunomodulatory proteolipid particle Caballero Aguirrechu 1, C. Mesa 2, R. Alvarez 2, L. Oliver 2, D. Gomez 1, R....
External validation of the Grade, Age, Nodes and Tumor (GRANT) score for patients with surgically treated papillary renal cell carcinoma Maffezzoli 1, A. Signori 2, S. Buti 1 (1) Medical...
Adopting the Sectra Lesion Tracking Tool for RECIST 1.1 in Renal Cell Cancer patients: First in the UK Pilot Study Ghose 1, S. Bhargava 1, S. Banerjee 1, R. Rabbani 1, K. Weerasinghe 1, N....
The prognostic impact of the metastatic pattern in advanced Renal Cell Carcinoma (aRCC): a retrospective analysis of 306 patients (pts) treated with compassionate ipilimumab and nivolumab (IPI+NIVO)...
Real word data of first-line metastatic renal cell carcinoma (mRCC) treatment choice in a tertiary centre in the UK Vijay 1, T. Jayasinghe 1, A. Bhatia 1, S. Sunil 1, E. Scott 1, G. Faust 1,...
Carboplatin AUC10 in metastatic Seminoma (Topic: "Real world evidence (except case studies)") R. Eldebri 1, J. Shamash 1 (1) Barts Health NHS Trust - United Kingdom This study presents a...
Remote Consultation in Prostate Cancer Clinics: Impact on Carbon Footprint and Patient Satisfaction Khan 1, C. Kent 1, F. Clark 1 (1) University Hospitals Leicester, Leicester - United Kingdom...
Serum levels of Thymidine Kinase 1 correlate with PSA and tumour shrinkage in metastatic Hormone Sensitive Prostate Cancer (mHSPC) Di Costanzo 1, S. Belli 1, G. Pecoraro 1, F. Migliaccio 1, C....
Transcriptomic Analysis of Patients with Metastatic Hormone-Sensitive Prostate Cancer to Identify Genomic Signatures Involved in the Transition from Androgen-Dependent to Androgen-Independent...
Prostate-Specific Membrane Antigen PET-CT findings in biochemical relapse after prostatectomy Artingstall 1, A. Mohamed 1, M. Beresford 1 (1) Royal United Hospital, Bath - United Kingdom ...
A case of brain metastasis development despite PSA suppression in a hormone sensitive metastatic prostate cancer patient under apalutamide treatment Stumbo 1, C. Mone 2, G. Tonini 1 (1)...
Evaluating Outcome and Prognostic Factors in Low-Volume Stage IV Hormone-Sensitive Prostate Cancer (mHSPC) M.A. Hassan 1, S. Anpalakhan 2, N. Osman 1, M. Gyi 1, S. Acharige 1, H. Yusof 1, N....
Southampton experience of prostate specific membrane antigen therapy for metastatic prostate cancer Sundram 1, Z. Saad 1, J. Wilkins 1, C. Longstaff 1 (1) University Hospitals Southampton NHS...
Real-life Analysis of [177Lu]Lu-PSMA-617 on mCRPC Patients cohort treated in France Roubaud 1, F. Somme 2, P. Barthélémy 3, P. Olivier 4, V. Massard 5, A. Giraudet 6, A. Flechon 6, S. Girault 7, S....
Prostate cancer (PC) and homologous recombination repair genes mutations (HRRm): a retrospective, monocentric, observational study aimed at recording histopathological and clinical data and their...